Related Experiment Video
Updated: Jul 31, 2025

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
Development of a novel shared decision making aid for primary immunodeficiency diseases
Spiros Tzivelekis1, Jordan Orange2, Christine Poulos3
1Takeda, 650 East Kendall Street, Cambridge, MA 02142, USA.
A new shared decision-making (SDM) tool was developed for primary immunodeficiency diseases (PID) treatment with immunoglobulin replacement therapy (IGRT). This aid helps patients and doctors make informed treatment choices.
Area of Science:
- Immunology
- Patient Care
Background:
- Primary immunodeficiency diseases (PID) require complex treatment decisions.
- Immunoglobulin replacement therapy (IGRT) is a common treatment for PID.
- Shared decision-making (SDM) is crucial for optimizing patient outcomes.
Purpose of the Study:
- To describe the development of an SDM aid for PID treatment using IGRT.
- To refine the SDM aid through expert and patient feedback.
Main Methods:
- Expert engagement and qualitative formative research guided aid development.
- Object-case best-worst scaling (BWS) prioritized IGRT administration features.
- The aid was assessed by US adults with PID and immunologists.
Main Results:
- Patients found the SDM aid useful and accessible.
- Best-worst scaling (BWS) methodology was supported by participants.
- Participant feedback led to refinements in aid content and BWS exercises.
Conclusions:
- Formative research successfully improved an SDM aid and BWS exercise for PID.
- The developed aid can enhance treatment decision-making for PID patients on IGRT.
- This tool may particularly benefit less-experienced patients and streamline SDM.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cystic Fibrosis: Management
Sinus disease and chronic...

